The document discusses using social norms marketing to de-normalize smoking and reduce tobacco use. It notes that people's behavior is strongly influenced by perceived norms (what they think others do), not just actual norms. Effective interventions include both changing individual behaviors and social/physical environments to make smoking less acceptable and accessible. The document proposes using local data to show communities accurate norms of low smoking and smoke-free homes/cars to reshape perceptions and social norms around tobacco use.
This was a presentation for the E cigarette summit 2015 on challenges for local public health systems
The presentations and agenda will all be uploaded here http://www.e-cigarette-summit.com/
This was a presentation for the E cigarette summit 2015 on challenges for local public health systems
The presentations and agenda will all be uploaded here http://www.e-cigarette-summit.com/
This is my presentation to the Hertfordshire Tobacco Control Alliance Conference for 21st January 2016. It's intended to be a think piece, a look at strategic challenges facing tobacco control and smoking cessation, and examine whether and how ecigarettes can be a help in addressing them
Ethical issue in Cigarette Industry.pptxNischalDBBA
Ethical Issue in Cigarette Industry through 3 Perspective that is Government, Business Houses and Society. This presentation is basically about the various effects cigarette industries causes and also its effects . The meaning of business ethics.
This World Cancer Day, know alarming statistics about smoking. Know how smoking affects your body very badly and how quit smoking change your body towards healthy life. Quitting smoking greatly reduces your risk for numerous diseases like cancers, COPD, and many more.
Indus Health Plus provides best preventive health checkup packages such as heart checkup, full body checkup packages, fitness checkup, annual corporate checkup, executive checkup, couple checkup and family health checkup at 50% less than market cost with same day reports.
Get avail health checkup packages at http://bit.ly/2m2nQf3
Call Us: 0-90490-22222
Jay Colum, nicotine dependency specialist for the Hamilton County Health Department, was the the speaker at the August 5 meeting of the Chattanooga Area’s Southside Council.
Colum’s topic was "Tobacco Control in Tennessee and Resources for Quitters."
Colum provided business people with the following information:
* How Tennessee smoking policies affect you
* How to help cut down on second-hand smoke
* How to make your environment healthier
Colum has worked in addictions therapy for over 20 years, focusing on providing addiction therapy to families. For the last five years he has provided tobacco control and education through the Health Department. He is responsible for maintaining a Tobacco Community Coalition, which includes the Smoke-Free Chattanooga campaign. Collum is seeking volunteers with an interest in helping change the culture of tobacco in Tennessee.
Tobacco Retail Report 2013 - Selling Tobacco Anywhere, Anytime Harmful Not He...Cancer Council NSW
Tobacco use remains an urgent health and social problem. Reform of the tobacco
retail environment would help achieve the NSW Government’s policy goals.
In the state plan, NSW 2021, the NSW Government has targets to lower smoking
rates by 3% for non-Aboriginal people and 4% for Aboriginal people by 2015.
1.Under the National Partnership Agreement on Preventative Health, the Government has committed to reduce daily smoking among adults to 10% or lower by 2020.
2. The NSW Minister for Health has endorsed the National Tobacco Strategy 2012–2018, undertaking to consider further options for tobacco retailer licensing and to commission
research on regulatory approaches to control the number and type of tobacco outlets.
3. Tobacco, a product that kills half its long-term users and is Australia’s leading
cause of preventable death and disease, is startlingly easy to buy. Cigarettes are available ‘anywhere, anytime’ – a legacy of the time when society was ignorant of their dire health effects. There are few limits on who may sell tobacco, where and when they may sell, or the number of outlets selling tobacco.
4. There are more than five times as many places to buy tobacco in NSW as there
are places to buy prescription medicines.
Visit canact.com.au for more information
This is my presentation to the Hertfordshire Tobacco Control Alliance Conference for 21st January 2016. It's intended to be a think piece, a look at strategic challenges facing tobacco control and smoking cessation, and examine whether and how ecigarettes can be a help in addressing them
Ethical issue in Cigarette Industry.pptxNischalDBBA
Ethical Issue in Cigarette Industry through 3 Perspective that is Government, Business Houses and Society. This presentation is basically about the various effects cigarette industries causes and also its effects . The meaning of business ethics.
This World Cancer Day, know alarming statistics about smoking. Know how smoking affects your body very badly and how quit smoking change your body towards healthy life. Quitting smoking greatly reduces your risk for numerous diseases like cancers, COPD, and many more.
Indus Health Plus provides best preventive health checkup packages such as heart checkup, full body checkup packages, fitness checkup, annual corporate checkup, executive checkup, couple checkup and family health checkup at 50% less than market cost with same day reports.
Get avail health checkup packages at http://bit.ly/2m2nQf3
Call Us: 0-90490-22222
Jay Colum, nicotine dependency specialist for the Hamilton County Health Department, was the the speaker at the August 5 meeting of the Chattanooga Area’s Southside Council.
Colum’s topic was "Tobacco Control in Tennessee and Resources for Quitters."
Colum provided business people with the following information:
* How Tennessee smoking policies affect you
* How to help cut down on second-hand smoke
* How to make your environment healthier
Colum has worked in addictions therapy for over 20 years, focusing on providing addiction therapy to families. For the last five years he has provided tobacco control and education through the Health Department. He is responsible for maintaining a Tobacco Community Coalition, which includes the Smoke-Free Chattanooga campaign. Collum is seeking volunteers with an interest in helping change the culture of tobacco in Tennessee.
Tobacco Retail Report 2013 - Selling Tobacco Anywhere, Anytime Harmful Not He...Cancer Council NSW
Tobacco use remains an urgent health and social problem. Reform of the tobacco
retail environment would help achieve the NSW Government’s policy goals.
In the state plan, NSW 2021, the NSW Government has targets to lower smoking
rates by 3% for non-Aboriginal people and 4% for Aboriginal people by 2015.
1.Under the National Partnership Agreement on Preventative Health, the Government has committed to reduce daily smoking among adults to 10% or lower by 2020.
2. The NSW Minister for Health has endorsed the National Tobacco Strategy 2012–2018, undertaking to consider further options for tobacco retailer licensing and to commission
research on regulatory approaches to control the number and type of tobacco outlets.
3. Tobacco, a product that kills half its long-term users and is Australia’s leading
cause of preventable death and disease, is startlingly easy to buy. Cigarettes are available ‘anywhere, anytime’ – a legacy of the time when society was ignorant of their dire health effects. There are few limits on who may sell tobacco, where and when they may sell, or the number of outlets selling tobacco.
4. There are more than five times as many places to buy tobacco in NSW as there
are places to buy prescription medicines.
Visit canact.com.au for more information
A series of practical resources to enable leaders and professionals with direct reach to communities and an established, trusted relationship, for example community leaders, social prescribing link workers and faith leaders, to support their communities to reduce their risk of becoming seriously ill from Covid-19
How to Make the Facts Matter: Using Data to Tell Your StoryPractical Playbook
by Elizabeth Jacob, Project Director, CityHealth.org
The Practical Playbook
National Meeting 2016
www.practicalplaybook.org
Bringing Public Health and Primary Care Together: The Practical Playbook National Meeting was at the Hyatt Regency in Bethesda, MD, May 22 - 24, 2016. The meeting was a milestone event towards advancing robust collaborations that improve population health. Key stakeholders from across sectors – representing professional associations, community organizations, government agencies and academic institutions – and across the country came together at the National Meeting to help catalyze a national movement, accelerate collaborations by fostering skill development, and connect with like-minded individuals and organizations to facilitate the exchange of ideas to drive population health improvement.
The National Meeting was also a significant source of tools and resources to advance collaboration. These tools and resources are available below and include:
Session presentations and materials
Poster session content
Photos from the National Meeting
The conversation started at the National Meeting is continuing in a LinkedIn Group "Working Together for Population Health" and Twitter. Use #PPBMeeting to provide feedback on the National Meeting.
The Practical Playbook was developed by the de Beaumont Foundation, the Duke University School of Medicine Department of Community and Family Medicine, the Centers for Disease Control and Prevention (CDC), and the Health Resources & Services Administration (HRSA).
CDC Update: Joining Forces to Reduce Tobacco and Cancer Among Behavioral Heal...sfary
From the the first Annual National Conference on Tobacco and Behavioral Health, which occurred May 19-20, 2014 in Bethesda, MD and was hosted by the Central East Addiction Technology Transfer Center, a program of The Danya Institute. You can see videos from the conference on our website www.ceattc.org (go to “Tobacco and Behavioral Health Resources” under “Special Topics”).
Tim McAfee, MD, MPH, is Director of CDC’s Office on Smoking and Health (OSH) within the National Center for Chronic Disease Prevention and Health Promotion. He is responsible for providing leadership and direction for all scientific, policy, and programmatic issues related to tobacco control and prevention. Before ed his residency training at Group Health Cooperative in Seattle and completed a fellowship at the University of Washington. Dr. McAfee has been a principal investigator and co-investigator on numerous research studies focusing on questions related to the effectiveness and dissemination of telephone- and Web-based tobacco cessation programs in medical systems and through government-sponsored quitlines. He helped found and served on the Board of Directors of the North American Quitline Consortium as well as numerous state and national tobacco policy advisory groups. He also authored the World Health Organization’s quitline manual for low- and middle-income countries.
This presentation is a take on what local authorities can do on reducing smoking in a world where e-cigarettes are and important tool . For the Public Policy Exchange Conference on July 12th 2016.
This presentation was given to the national Public Health Stakeholder Forum for England on 21 January 2015. It covers my take on tobacco control priorities and work we need to do
Regulating Lifestyle - The Emergence of a New European Policy on Alcohol, Die...Alberto Alemanno
Should governments regulate lifestyle by developing a lifestyle policy, affecting tobacco, alcohol and diets? Should they be allowed to change individual behavior to attain legitimate public health goals, such as higher life expectancy and improved public health?
The European Union has recently recognized the growing impact of NCDs, including cardiovascular diseases, cancers, chronic respiratory diseases and diabetes, on the EU's economy and the well-being of its citizens and has consequently started to develop policies intended to tackle the four main factors to which they are linked. Nevertheless, if common themes emerge between the different EU policies intended to promote healthier lifestyles, no attempt has yet been made to systematize them.
NYU College of Global Health - E-cigarette seminar - New YorkClive Bates
E-Cigarettes: The Tectonic Shift in Nicotine and Tobacco Consumption: Opportunity or Threat to Saving Lives?
Clive Bates
Friday, October 19, 2018
NYU School of Law, Greenberg Lounge
40 Washington Square South, New York, New York
Dr. Terry F. Pechacek, professor of health management and policy at the School of Public Health at Georgia State University, discusses strategies for tobacco control, including the impact of of e-cigarettes.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
1. Scott Crosby Regional Social Marketing Manager [email_address]
2.
3. 1936: A Philip Morris advert states: “their (group of doctors) tests proved conclusively that on changing to Philip Morris, every case of irritation due to smoking cleared completely or definitely improved”
15. * Source: Independent survey by Tangible Branding Limited, February 2010. In blind head-to-head tests between Costa's Flat White and a Flat White from Starbucks, 62% of respondents who identified themselves as 'Coffee Lovers' preferred Costa's Flat White. Total sample size 157. Number of participants identifying themselves as coffee lovers: 84.
![Scott Crosby Regional Social Marketing Manager [email_address]](https://image.slidesharecdn.com/f2-tonudgeortoshove-scottcrosby-110711093528-phpapp02/85/F2-to-nudge-or-to-shove-scott-crosby-1-320.jpg)
